Concentration of MitoQ in Human Skeletal Muscle (MitoQ/muscle)

University of Copenhagen

Status: Unknown

Conditions: Healthy

Treatments: Dietary Supplement: MitoQ

Study type: Interventional

Funder types: Other

Identifiers

NCT04098510

MitoQ

Details and patient eligibility

About

The purpose of this study is to determine mitoquinone mesylate concentration levels in skeletal muscle samples obtained after intake of an acute oral dose of MitoQ.

Enrollment: 10 estimated patients

Sex: Male

Ages: 18 to 40 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy,
• Male
• 18-40 years of age

Exclusion criteria

• Previous use of MitoQ or CoQ-10 within 30 days of screening appointment
• Ongoing use of MitoQ
• Smoking
• Ongoing treatment with medications
• Disease deemed by the MD to infer a risk to participate in the trial

Trial design

Primary purpose: Basic Science

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

10 participants in 1 patient group

MitoQ

Experimental group

Description:

Subjects ingest 160 mg of MitoQ

Treatment:

Dietary Supplement: MitoQ